Seattle biotech firm Kineta raises $1.6 million to boost its battle against disease
Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company. The investment will be used to fund continued development of the drugs that the company is working on. “This new raise comes from existing investors and shows confidence in what the Kineta team is doing and […]